Cytoprotective function of nitric oxide: inactivation of superoxide radicals produced by human leukocytes

Biochem Biophys Res Commun. 1991 Dec 31;181(3):1392-7. doi: 10.1016/0006-291x(91)92093-y.

Abstract

The oxygen-derived free radical superoxide anion (.O2-) plays an important role in the pathogenesis of various diseases. Recent demonstrations that .O2- inactivates the potent vasodilator endothelium-derived relaxing factor (EDRF) and that EDRF is probably nitric oxide (NO) suggest that EDRF(NO) may act as an endogenous free radical scavenger. This hypothesis was tested in an in vitro system by analyzing the effect of authentic NO (dilutions of a saturated aqueous solution) on .O2- production (detected spectrophotometrically as reduction of cytochrome c) by fMet-Leu-Phe-activated human leukocytes (PMN). NO depressed the rate of reduction of cytochrome c by .O2- released from PMN's or generated from the oxidation of hypoxanthine by xanthine oxidase. This effect was concentration-dependent and occurred at dilutions of the saturated NO solution (1:250 to 1:10) which inhibited platelet aggregation. NO had no direct effect on cytochrome c or on xanthine oxidase. These observations indicate that NO(EDRF) can be regarded as a scavenger of superoxide anion and they suggest that EDRF(NO) may provide a chemical barrier to cytotoxic free radicals (.O2-).

Publication types

  • Comparative Study

MeSH terms

  • Adenosine Diphosphate / pharmacology
  • Cytochalasin B / pharmacology
  • Cytochrome c Group / metabolism
  • Humans
  • In Vitro Techniques
  • Kinetics
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology
  • Neutrophils / drug effects
  • Neutrophils / physiology*
  • Nitric Oxide / pharmacology*
  • Platelet Aggregation / drug effects*
  • Superoxides / blood*
  • Xanthine Oxidase / metabolism

Substances

  • Cytochrome c Group
  • Superoxides
  • Nitric Oxide
  • Cytochalasin B
  • N-Formylmethionine Leucyl-Phenylalanine
  • Adenosine Diphosphate
  • Xanthine Oxidase